Clinical trials: Oral Melanoma

Melanoma

Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma

• Completed
• Age: 18 years and older
• Phase 2
• Results posted

This study will test whether an experimental drug called Revlimid (lenalidomide) can reduce tumor size and prolong survival in patients with metastatic melanoma (melanoma that has spread beyond the original tumor site).

Trial name

NCT00109005

Testing

Revlimid

Where

United States

Volunteers

17 people

Sponsor

National Cancer Institute (NCI)